TREM‐1 contributes to the pathogenesis of RA and may serve as a promising therapeutic target in RA to suppress the specific inflammatory response while preserving the immune system's ability to fight off infections 9, 10, 11, 13, 18, 29. The gene discussed is TREM1; the disease is rheumatoid arthritis.